Pharmaceuticals

Latest California Healthline Stories

KHN’s ‘What The Health?’: Democrats Do Drugs (Prices)

House Democrats start legislative work on House Speaker Nancy Pelosi’s prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump’s health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Think ‘Medicare For All’ Is The Only Democratic Health Plan? Think Again

The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates’ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.

California’s New Transparency Law Reveals Steep Rise In Wholesale Drug Prices

Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California’s first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.

As Medicare Enrollment Nears, Popular Price Comparison Tool Missing Key Details

For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.